Radioimmunotherapy of ovarian cancer with intravenously administered iodine-131 labeled chimeric Mov18 monoclonal antibody

C.F. Molthoff, M.A.B.D. Plaizier, I. van Zanten-Przybysz, G.W.M. Visser, P. Kenemans, RHM Verheijen, J.C. Roos

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{d8e7c8d01288477b918f407ebea1d144,

title = "Radioimmunotherapy of ovarian cancer with intravenously administered iodine-131 labeled chimeric Mov18 monoclonal antibody",

author = "C.F. Molthoff and M.A.B.D. Plaizier and {van Zanten-Przybysz}, I. and G.W.M. Visser and P. Kenemans and RHM Verheijen and J.C. Roos",

year = "1999",

language = "English",

volume = "40",

pages = "966",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

}

TY - JOUR

T1 - Radioimmunotherapy of ovarian cancer with intravenously administered iodine-131 labeled chimeric Mov18 monoclonal antibody

AU - Molthoff, C.F.

AU - Plaizier, M.A.B.D.

AU - van Zanten-Przybysz, I.

AU - Visser, G.W.M.

AU - Kenemans, P.

AU - Verheijen, RHM

AU - Roos, J.C.

PY - 1999

Y1 - 1999

M3 - Article

SN - 0161-5505

VL - 40

SP - 966

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

ER -